BEST-CLI Clinical Trial Focuses on Optimal Treatment for Limb-Threatening Ischemia

Significant findings from the “BEST-CLI — Best Endovascular versus Best Surgical Therapy for Patients with Critical Limb Ischemia”  clinical trial were presented Nov. 7 during the American Heart Association Scientific Sessions (AHA2022).

Related Keywords

Boston , Massachusetts , United States , Boston University , Canada , American , Canadian , Kenneth Rosenfield , Markj Cziraky , Niteesh Choudhry , Alik Farber , Matthew Menard , Kenneth Rosenfeld , Taye Hamza , Endovascular Surgery Society , Division Of Vascular , Society For Vascular Medicine , Midwest Vascular Surgery Society , American Heart Association Scientific Sessions , Division Of Cardiology , Boston University Chobanian Avedisian School Of Medicine , Cardiovascular Systems Inc , Southern Association Of Vascular Surgeons , Blood Institute , Novo Nordisk Foundation , National Heart , Canadian Society For Vascular Surgery , Boston Medical Center , Becton Dickinson , National Institutes Of Health , Chobanian Avedisian School Of Medicine , Eastern Vascular Society , Boston Scientific , Society For Vascular Surgery , Endovascular Surgery Program , Society For Clinical Vascular Surgery , England Society For Vascular Surgery , Medtronic , Society Of Interventional Radiology , Vascular Society , Best Endovascular , Best Surgical Therapy , Critical Limb Ischemia , New England Journal , Mass General Brigham , Massachusetts General Hospital , Endovascular Surgery , Boston University Chobanian , Avedisian School , Artery Disease , Major Adverse Limb Events , Vascular Medicine , National Institutes , Vascular Interventional Advances , Vascular Surgery , New England Society , Western Vascular Society , Southern Association , Vascular Surgeons , Canadian Society , Clinical Vascular Surgery , Interventional Radiology , Cardiovascular Systems ,